can taking tirzepatide cause uti Help You Lose Weight? tirzepatide uti risk linked to

doi: 10.1016/j.jneb.2009.03.001

Human Growth Hormone and Anti-Aging

Funding for this work was provided by an Institutional Development Fund to the Center for Applied Genomics from Childrens Hospital of Philadelphia and a sponsored Research agreement with Artic Therapeutics LLC

Within a year of stopping their initial GLP-1 medication, many patients explored other weight management strategies: 27% switched to another medication (including older-generation obesity drugs or switching between semaglutide and tirzepatide) 20% restarted their original medication 14% continued treatment through lifestyle-focused care with professionals such as dietitians or exercise specialists Less than 1% underwent metabolic and bariatric surgery Ongoing Support Key to Long-Term Weight Management Researchers say these findings highlight the importance of continued, individualized care for people managing obesity, even if they stop medication

Across all four STEP clinical trials, participants who received semaglutide lost an average of between 10% and 17% of their body weight